RECORDATI
Manufacturing · Italy · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Via Matteo Civitali 1, Milano, Lombardy,...Phone Number
+39 2487871Website
www.recordati.comRevenue
$2 BillionStock Symbol
RECIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About RECORDATI
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operaRead more
RECORDATI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RECORDATI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when RECORDATI launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once RECORDATI has new funding data
Check out if RECORDATI is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at RECORDATI
Click to see if RECORDATI had a recent Job posting/layoffs
RECORDATI, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on RECORDATI recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if RECORDATI has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at RECORDATI
Find 3 more new buyers
Company Profile Activity
Activity Insights
RECORDATI is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RECORDATI is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RECORDATI.
RECORDATI Tech Stack
A closer look at the technologies used by RECORDATI
Most Recent Scoops
Person-Based
Acquisitions
Open Position
Open Position
Earnings
RECORDATI has reported that within the SPC segment for Q1, urology delivered a positive performance driven by Avodart/Combodart and Eligard, which grew 5.5% year on year.
Earnings, Pharmaceuticals, Finance
Earnings
Mergers & Acquisitions, Earnings, Accounting, Financial Planning, Business Development, Financial Reporting, Acquisitions, Finance, Financial Strategy, Mergers
RECORDATI News & Media
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA +5.0%, ADJUSTED NET INCOME +7.2%RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA +14.5%, ADJUSTED NET INCOME +14.5%RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA
RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RECORDATI
Sign Up For FreeTo access detailed company insights
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, an... Read More
